Area of research
Immunology · Infectious Diseases
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, Immune Cell Function and Interaction, HIV Research and Treatment, and Monoclonal and Polyclonal Antibodies Research.
Potent neutralization by a RBD antibody with broad specificity for SARS-CoV-2 JN.1 and other variants
Aerosol delivery of SARS-CoV-2 human monoclonal antibodies in macaques limits viral replication and lung pathology
Immunization with Recombinant Accessory Protein-Deficient SARS-CoV-2 Protects against Lethal Challenge and Viral Transmission
Highly Cross-Reactive and Protective Influenza A Virus H3N2 Hemagglutinin- and Neuraminidase-Specific Human Monoclonal Antibodies
Fc-Effector-Independent in vivo Activity of a Potent Influenza B Neuraminidase Broadly Neutralizing Antibody
Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody
Monitoring SARS-CoV-2 Infection Using a Double Reporter-Expressing Virus
Baseline host determinants of robust human HIV-1 vaccine-induced immune responses: A meta-analysis of 26 vaccine regimens
Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern
Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters
Generation and Characterization of Recombinant SARS-CoV-2 Expressing Reporter Genes
Duration of post–COVID-19 symptoms is associated with sustained SARS-CoV-2–specific immune responses
Analysis of SARS-CoV-2 infection dynamic in vivo using reporter-expressing viruses
Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection
Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2
Broad and Protective Influenza B Virus Neuraminidase Antibodies in Humans after Vaccination and their Clonal Persistence as Plasma Cells
A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody